Evidence map›Paper›PMID 38425691›Full record

ArticleClinical and translational radiation oncology2024

Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveys.

Monica-Emila Chirilă, Fatjona Kraja, Gustavo Nader Marta, Wellington Furtado Pimenta Neves Junior, Gustavo Viani de Arruda, André Guimarães Gouveia, Pierfrancesco Franco, Philip Poortmans, Ivica Ratosa

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 6 countries.

Monica-Emila ChirilăRadiation Oncology Department, Amethyst Radiotherapy Centre, Cluj-Napoca, Romania.
Fatjona KrajaSurgery Department, Faculty of Medicine, University of Medicine Tirana, Albania.
Gustavo Nader MartaDepartment of Radiation Oncology, Hospital Sirio Libanês, São Paulo, Brazil.
Wellington Furtado Pimenta Neves JuniorDepartment of Radiation Oncology, Hospital Sirio Libanês, São Paulo, Brazil.
Gustavo Viani de ArrudaLatin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
André Guimarães GouveiaLatin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Pierfrancesco FrancoDepartment of Translational Sciences (DIMET), University of Eastern Piedmont, Novara, Italy.
Philip PoortmansDepartment of Radiation Oncology, Faculty of Medicine and Health Sciences, University of Antwerp, Iridium Netwerk, Wilrijk-Antwerp, Belgium.
Ivica RatosaDivision of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Universidade de São Paulo · BRJuravinski Cancer Centre · CAUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Antwerp · BEUniversity of Ljubljana · SIUniversity of Medicine Tirana · AL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Advances in local and systemic therapies have improved the outcomes of patients with breast cancer (BC), leading to a possible increased risk for postoperative radiation therapy (RT) late adverse events. The most adequate technologies and dose constraints for organs at risk (OAR) in BC RT have yet to be defined. Methods: An online survey was distributed to radiation oncologists (ROs) practicing in Europe and Latin America including the Caribbean (LAC) through personal contacts, RO and BC professional groups' networks. Demographic data and clinical practice information were collected. Results: The study included 585 responses from ROs practicing in 57 different countries. The most frequently contoured OAR by European and LAC participants were the whole heart (96.6 % and 97.7 %), the ipsilateral (84.3 % and 90.8 %), and contralateral lung (71.3 % and 77.4 %), whole lung (69.8 % and 72.9 %), and the contralateral breast (66.4 % and. 83.2 %). ESTRO guidelines were preferred in Europe (33.3 %) and the RTOG contouring guideline was the most popular in LAC (62.2 %), while some participants used both recommendations (13.2 % and 19.2 %). IMRT (68.6 % and 59.1 %) and VMAT (65.6 % and 60.2 %) were the preferred modalities used in heart sparing strategies, followed by deep inspiration breath-hold (DIBH) (54.8 % and 37.4 %) and partial breast irradiation (PBI) (41.6 % and 24.6 %). Only a small percentage of all ROs reported the dose-volume constraints for OAR used in routine clinical practice. A mean heart dose (Heart-D Conclusion: The delineation approaches and sparing techniques for OAR in BC RT vary between ROs worldwide. The low response rate to the dose constraints subset of queries reflects the uncertainty surrounding this topic and supports the need for detailed consensus recommendations in the clinical practice.

Indexed as

Breast cancerDose volume constraintsHeart sparingOrgans at riskRadiotherapySurvey

Identifiers

PMID38425691
PMCPMC10900109
OpenAlexW4391988968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.